HPV DNA testing in cervical cancer screening: Results from women in a high risk province of Costa Rica

JAMA

Volumn 283, Issue 1, 2000, Pages 87-93

  Schiffman, Mark ^a   Herrero, Rolando ^b   Hildesheim, Allan ^a   Sherman, Mark E ^c   Bratti, Maria ^d   Wacholder, Sholom ^a   Alfaro, Mario ^d   Hutchinson, Martha ^e   Morales, Jorge ^d   Greenberg, Mitchell D ^f   Lorincz, Attila T ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d Social Secty Admin of Costa Rica   (Costa Rica)

^e WOMEN AND INFANTS HOSPITAL   (United States)

^f Omnia Inc   (United States)

^g Digene Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; COSTA RICA; DNA DETERMINATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0034606668     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.1.87     Document Type: Article

References (31)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.
2. Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer; 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 64.
3. Bosch PX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 1995;87: 796-802.
4. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169:235-240.
5. Carter JJ, Koutsky LA, Wipf GC, et al. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis. 1996;174:927-936.
6. Nobberthuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical visions and consequences for cevical-cancer screening: a prospective study. Lancet. 1999;354:20-25.
7. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995. Cancer. 1998;82:1197-1207.
8. Schiffman MH, Sherman ME. HPV testing to improve cervical cancer screening. In: Srivastava S, Lippman SM, Hong WK, Mulshine JL, eds. Early Detection of Cancer: Molecular Markers. Armonk, NY: Futura Publishing Co Inc; 1994:265-277.
9. Cox JT. HPV testing. J Fam Pract. 1998;46:121-124.
10. Schneider A, Zahm DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3. Am J Obstet Gynecol. 1996;174:1534-1541.
11. Kaufman RH, Adam E, Icenogie J, Reeves WC. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Am J Obstet Gynecol. 1997;177:930-936.
12. Crum CP. Detecting every genital papilloma virus infection: what does it mean? Am J Pathol. 1998; 153:1667-1671.
13. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189: 12-19.
14. Schiffman MH. Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern biot. in: Munoz N, Bosch FX, Shah KV, Meheus A. eds. The Epidemology of Cervical Cancer and Human Papillomavirus. Lyon, France: International Agency for Research on Cancer, 1992:169-179.
15. Kiviat NB, Koutsky LA, Clitchlow CW, et al. Comparison of Southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33, and 35. Am J Clin Pathol. 1990;94:561-565.
16. Schiffman MH, Burk RD. Human papillomaviruses. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans. 4th ed; New York, NY: Plenum Medical Publishing Co; 1997:983-1023.
17. Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Pan Am J Public Health. 1997;1:362-374.
18. Brinton LA, Reeves WC, Brenes MM, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer. 1989; 44:199-203.
19. Herrero R, Brinton LA, Hartge P, et al. Determinants of the geographic variation of invasive cervical cancer in Costa Rica. Bull Pan Am Health Organ. 1993; 27:15-25.
20. Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening. Cancer. 1999;87:48-55.
21. Schneider DL, Herrero R, Bratti C, et al. Cervicography screening for cervical cancer among 8,460 women in a high-risk population. Am J Obstet Gynecol. 1999;180:290-298.
22. Sherman ME, Schiffman M, Herrero R, et al. Performance of a semiautomated Papanicolaou smear screening system. Cancer. 1998;84:273-280.
23. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by Hybrid Capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol, 1996;172:946-954.
24. Peyton CL, Schiffman MH, Lorincz AT, et al. Comparison of PCR-and Hybrid Capture-based human papillomavirous detection systems using multiple cervical specimen collection strategies. J Clin Microbiol. 1998;36:3248-3254.
25. Lorincz A. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep. 1996;7:1-5.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots. Clin Chem. 1993;39:561-577.
27. The ALTS Group. HPV testing as a triage strategy for women with cytologic evidence of low-grade squamous intraepithelial lesions. J Natl Cancer Inst. In press.
28. Johnson MA, Blomfield PI, Bevan IS, Woodman CB, Young LS. Analysis of human papillomavirus type 16 E6-E7 transcription in cervical carcinomas and normal cervical epithelium using the polymerase chain reaction. J Gen Virol 1990;71:1473-1479.
29. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer. 1994;69: 167-171.
30. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141:680-689.
31. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus. J Clin Microbiol. 1997;35: 1304-1310.